Works matching DE "AFLIBERCEPT"

Results: 352

Patolojik Miyopiye Sekonder Koroidal Neovaskülarizasyon Olgularında Farklı Anti-VEGF Ajanların Etkinliğinin Karşılaştırılması: 4 Yıllık Gerçek Yaşam Verileri.

Published in:

MN Opthalmology / MN Oftalmoloji, 2024, v. 31, n. 4, p. 190

By:

ÖZBEK, Merve;
ÖZÇALIŞKAN, Şehnaz;
ARTUNAY, Özgür

Publication type:

Article

Clinical outcomes of a treat-and-extend regimen with intravitreal aflibercept injections in patients with choroidal neovascularization secondary to chronic central serous chorioretinopathy.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2024, n. 4, p. 46, doi. 10.31288/oftalmolzh202444651

By:

Kustryn, T. B.;
Zadorozhnyy, O. S.;
Nasinnyk, I. O.;
Nevska, A. O.;
Pasyechnikova, N. V.;
Korol, A. R.

Publication type:

Article

Features of aflibercept plus hyperbaric oxygen therapy for diabetic macular edema.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2022, n. 4, p. 18, doi. 10.31288/oftalmolzh202241822

By:

Drozdov, V. O.;
Sakovych, V. M.

Publication type:

Article

Ultrastructural features of epiretinal membranes after intravitreal injection of various doses of aflibercept in patients with proliferative diabetic retinopathy.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2021, n. 6, p. 25, doi. 10.31288/oftalmolzh202162530

By:

Ponomarchuk, Vira S.;
Molchaniuk, N. I.;
Umanets, M. M.

Publication type:

Article

Morphological and ophthalmoscopic features of epiretinal membranes after intravitreal injection of various doses of aflibercept in patients with proliferative diabetic retinopathy.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2021, n. 5, p. 3, doi. 10.31288/oftalmolzh2021539

By:

Ponomarchuk, Vira S.;
Vit, V. V.;
Umanets, M. M.

Publication type:

Article

Effect and factors associated with reactivation after intravitreal conbercept or aflibercept in retinopathy of prematurity.

Published in:

European Journal of Medical Research, 2025, v. 30, n. 1, p. 1, doi. 10.1186/s40001-024-02206-7

By:

Huang, Chunling;
Zou, Weikang;
Ma, Wenbei;
Li, Jiali;
Bai, Yichen;
Wu, Rong;
Li, Qiqi;
Fang, Qi;
Chen, Wenna;
Lu, Xiaohe;
Feng, Songfu

Publication type:

Article

Factors Associated with Success of Switching to Faricimab for Neovascular Age-Related Macular Degeneration Refractory to Intravitreal Aflibercept.

Published in:

Life (2075-1729), 2024, v. 14, n. 4, p. 476, doi. 10.3390/life14040476

By:

Machida, Akira;
Oishi, Akio;
Ikeda, Junichiro;
Kurihara, Junko;
Yoneda, Ai;
Tsuiki, Eiko;
Hirata, Yuki;
Murakami, Ryuya;
Kitaoka, Takashi

Publication type:

Article

Tocilizumab and Aflibercept as a Treatment Option for Refractory Macular Edema after Acute Retinal Necrosis.

Published in:

Ocular Immunology & Inflammation, 2023, v. 31, n. 1, p. 242, doi. 10.1080/09273948.2021.2024580

By:

Bograd, Alexandra;
Villiger, Peter M.;
Munk, Marion R.;
Bolt, Isabel;
Tappeiner, Christoph

Publication type:

Article

OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept.

Published in:

2021

By:

Dastiridou, Anna;
Karathanou, Katerina;
Riga, Paraskevi;
Anagnostopoulou, Sofia;
Balasubramanian, Siva;
Mataftsi, Asimina;
Brazitikos, Periklis;
Ziakas, Nikolaos;
Androudi, Sofia

Publication type:

journal article

Comparison of Ranibizumab versus Aflibercept in Treating Macular Edema among Patients with Serous Retinal Detachment Secondary to Branch Retinal Vein Occlusion.

Published in:

2021

By:

Küçük, Bekir;
Sirakaya, Ender;
Karaca, Cagatay

Publication type:

journal article

Intravitreal Aflibercept for Diffuse Choroidal Hemangioma in Sturge-Weber Syndrome.

Published in:

2023

By:

El Mollayess, Georges;
Sleiman, Karim;
Ibrahim, Riwa;
Bleik, Jamal

Publication type:

Case Study

Outcomes of combination therapy using aflibercept and dexamethasone intravitreal implant versus dexamethasone monotherapy for macular edema secondary to retinal vein occlusion.

Published in:

Middle East African Journal of Ophthalmology, 2021, v. 28, n. 1, p. 18, doi. 10.4103/meajo.MEAJO_297_19

By:

Harb, Walid;
Chidiac, Georgio;
Harb, Georges

Publication type:

Article

The effect of antiangiogenic agent aflibercept on surgically induced endometriosis in a rat model.

Published in:

Cirugía y Cirujanos, 2024, v. 92, n. 1, p. 10, doi. 10.24875/CIRU.23000072

By:

Ates, Caglayan;
Dilbaz, Berna;
Ergani, Seval Yılmaz;
Atabay, Fuad

Publication type:

Article

Short-Term Comparison of Switching to Brolucizumab or Faricimab from Aflibercept in Neovascular AMD Patients.

Published in:

Medicina (1010660X), 2024, v. 60, n. 7, p. 1170, doi. 10.3390/medicina60071170

By:

Kin, Akiko;
Mizukami, Takahiro;
Ueno, Satoru;
Mishima, Soichiro;
Shimomura, Yoshikazu

Publication type:

Article

Treatment Effects of Switching to Faricimab in Eyes with Diabetic Macular Edema Refractory to Aflibercept.

Published in:

Medicina (1010660X), 2024, v. 60, n. 5, p. 732, doi. 10.3390/medicina60050732

By:

Tatsumi, Tomoaki;
Kaiho, Tomomi;
Iwase, Takehito;
Miura, Gen;
Shimizu, Daisuke;
Niizawa, Tomohiro;
Ozawa, Yoshihito;
Arai, Miyuki;
Oshitari, Toshiyuki;
Takatsuna, Yoko;
Baba, Takayuki

Publication type:

Article

Aflibercept for Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia: A Case Report.

Published in:

Medicina (1010660X), 2023, v. 59, n. 9, p. 1533, doi. 10.3390/medicina59091533

By:

Villanueva, Bernat;
Iriarte, Adriana;
Torres-Iglesias, Raquel;
Muñoz Bolaño, Miriam;
Cerdà, Pau;
Riera-Mestre, Antoni

Publication type:

Article

Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept.

Published in:

Medicina (1010660X), 2023, v. 59, n. 6, p. 1125, doi. 10.3390/medicina59061125

By:

Ohara, Hiromi;
Harada, Yosuke;
Hiyama, Tomona;
Sadahide, Ayako;
Minamoto, Akira;
Kiuchi, Yoshiaki

Publication type:

Article

Comparative Pharmacokinetic Analysis of Aflibercept and Brolucizumab in Human Aqueous Humor Using Nano-Surface and Molecular-Orientation Limited Proteolysis.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 2, p. 556, doi. 10.3390/ijms26020556

By:

Nagaoka, Kosuke;
Kimura, Natsuka;
Inoda, Satoru;
Takayama, Takuya;
Arai, Yusuke;
Yanagi, Yasuo;
Shimada, Takashi;
Nagai, Ryozo;
Takahashi, Hidenori;
Aizawa, Kenichi

Publication type:

Article

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy.

Published in:

2022

By:

Ferrante, Nicola;
Ritrovato, Daniela;
Bitonti, Rossella;
Furneri, Gianluca

Publication type:

journal article

Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1131, doi. 10.1007/s00432-022-03946-x

By:

Beom, Seung-Hoon;
Kim, Jong Gwang;
Baik, Seung Hyuk;
Shin, Seong Hoon;
Park, Inkeun;
Park, Young Suk;
Lee, Myung-Ah;
Lee, Soohyeon;
Jeon, So-Yeon;
Han, Sae-Won;
Kang, Myoung Hee;
Oh, Jisu;
Kim, Jin Soo;
Kim, Jin Young;
Ahn, Mi Sun;
Zang, Dae Young;
Bae, Byung-Noe;
Jo, Hong Jae;
Kim, Hee Kyung;
Kim, Jung-Han

Publication type:

Article

Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-14444-y

By:

Tatsumi, Tomoaki;
Takatsuna, Yoko;
Oshitari, Toshiyuki;
Kaiho, Tomomi;
Kawasaki, Yohei;
Shiko, Yuki;
Sugawara, Takeshi;
Baba, Takayuki;
Yamamoto, Shuichi

Publication type:

Article

Novel volumetric imaging biomarkers for assessing disease activity in eyes with PCV.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-06742-2

By:

Vyas, Chinmayi Himanshuroy;
Cheung, Chui Ming Gemmy;
Jordan-Yu, Janice Marie N.;
Shimizu, Hitoshi;
Tan, Anna Cheng Sim;
Sim, Shaun Sebastian;
Fenner, Beau James;
Akiba, Masahiro;
Chakravarthy, Usha;
Teo, Kelvin Yi Chong

Publication type:

Article

Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-99634-w

By:

Ma, I-Hsin;
Hsia, Yun;
Hsieh, Yi-Ting;
Ho, Tzyy-Chang;
Lai, Tso-Ting;
Yang, Chung-May;
Yang, Chang-Hao

Publication type:

Article

Gene expression profile of the murine ischemic retina and its response to Aflibercept (VEGF-Trap).

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94500-1

By:

Rojo Arias, Jesús Eduardo;
Jászai, József

Publication type:

Article

Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93899-x

By:

Jin, Ki Won;
Kim, Jae Hui;
Park, Jun Young;
Park, Sang Jun;
Park, Kyu Hyung;
Lee, Joo Yong;
Woo, Se Joon

Publication type:

Article

Successful Treatment of Hemi-Retinal Vein Occlusion with Macular Edema following Spinal Surgery Using Intravitreal Aflibercept and Retinal Photocoagulation: A Case Report.

Published in:

2024

By:

Nakatake, Shunji;
Sato, Yoshiki;
Itotani, Maho;
Kimoto, Kenichi;
Kubota, Toshiaki;
Takeda, Atsunobu

Publication type:

Case Study

Multimodal Imaging Findings in Retinopathy Associated with Facioscapulohumeral Muscular Dystrophy before and after Treatment with Intravitreal Aflibercept and Laser Photocoagulation.

Published in:

2022

By:

Shimizu, Hiroshi;
Shimizu, Masaki;
Nakano, Toshiya;
Noda, Kousuke;
Tanito, Masaki

Publication type:

Case Study

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration.

Published in:

2022

By:

Ali Said, Yasmin;
Vanwynsberghe, David;
Jacob, Julie

Publication type:

Case Study

Peripapillary Choroidal Neovascular Membrane Secondary to Sarcoidosis-Related Panuveitis: Treatment with Aflibercept and Ranibizumab with a 50-month Follow-Up.

Published in:

Case Reports in Ophthalmology, 2021, v. 12, n. 1, p. 186, doi. 10.1159/000512579

By:

Matsou, Artemis;
Dermenoudi, Maria;
Tzetzi, Despina;
Rotsos, Tryfon;
Makri, Olga;
Anastasopoulos, Eleftherios;
Symeonidis, Chrysanthos

Publication type:

Article

Bietti crystalline dystrophy complicated by choroidal neovascularization treated with a single dose of aflibercept.

Published in:

2023

By:

Ozbek, Merve;
Pehlivanoglu, Seren;
Artunay, Halil Ozgur

Publication type:

Case Study

Optical density changes of subretinal hyperreflective material in age-related macular degeneration after switching therapy from ranibizumab to aflibercept.

Published in:

Oman Journal of Ophthalmology, 2022, v. 15, n. 2, p. 182, doi. 10.4103/ojo.ojo_139_21

By:

Filik, Armagan;
Gungel, Hulya

Publication type:

Article

Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China.

Published in:

Annals of Medicine, 2023, v. 55, n. 1, p. 1, doi. 10.1080/07853890.2023.2227424

By:

Zhao, Tantai;
Li, Jiani;
Wang, Yanbin;
Guo, Xiaojian;
Sun, Yun

Publication type:

Article

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration.

Published in:

2024

By:

Nowosielska, Agnieszka

Publication type:

Case Study

Stanowisko Polskiego Towarzystwa Okulistycznego określające standardy prowadzenia terapii pacjentów z wysiękową postacią starczego zwyrodnienia plamki.

Published in:

Acta Ophthalmologica Polonica / Klinika Oczna, 2023, v. 125, n. 4, p. 181, doi. 10.5114/ko.2023.134018

By:

Misiuk-Hojło, Marta;
Bakunowicz-Łazarczyk, Alina;
Dobrowolski, Dariusz;
Grabska-Liberek, Iwona;
Mackiewicz, Jerzy;
Mrukwa-Kominek, Ewa;
Nowak, Agnieszka;
Pociej-Marciak, Weronika;
Romanowska-Dixon, Bożena;
Stopa, Marcin;
Szaflik, Jacek;
Kałużny, Jakub;
Adamiec-Mroczek, Joanna

Publication type:

Article

Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.

Published in:

JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 12, p. 1497, doi. 10.1093/jnci/djad120

By:

Pesántez, David;
Hoorn, Sanne ten;
Machado, Isidro;
García-Albéniz, Xabier;
Rodríguez-Salas, Nuria;
Heredia-Soto, Victoria;
Viñal, David;
Pericay, Carles;
García-Carbonero, Rocio;
Losa, Ferran;
Alonso, Vicente;
Vera, Ruth;
Batlle, Jaime Feliu;
Gallego, Javier;
Salud, Antonieta;
Nogué, Miquel;
Layos, Laura;
Montagut, Clara;
Capdevila, Jaume;
Vermeulen, Louis

Publication type:

Article

Production of a biosimilar version of aflibercept to improve VEGF blocker cytotoxicity on endothelial cells.

Published in:

Growth Factors, 2023, v. 41, n. 3, p. 140, doi. 10.1080/08977194.2023.2227271

By:

Ramezani, Amin;
Zareinejad, Mohammadrasul;
Mahmoudi Maymand, Elham;
Kaviani, Elina;
Ghaderi, Abbas

Publication type:

Article

High‑dose aflibercept injection has striking effects on myopic choroidal neovascularization.

Published in:

Experimental & Therapeutic Medicine, 2023, v. 25, n. 6, p. N.PAG, doi. 10.3892/etm.2023.12000

By:

Zhu, Wei;
Hao, Yanlei;
Yuan, Zhongfang;
Huang, Chunmei

Publication type:

Article

Effect of polyp regression and reduction on treatment efficacy in polypoidal choroidal vasculopathy treated with aflibercept.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-52448-y

By:

Sayanagi, Kaori;
Fujimoto, Satoko;
Hara, Chikako;
Fukushima, Yoko;
Maruyama, Kazuichi;
Kawasaki, Ryo;
Sato, Shigeru;
Nishida, Kohji

Publication type:

Article

Predictors of treatment outcomes following treat-and-extend regimen with aflibercept for branch retinal vein occlusion: post-hoc analysis of the PLATON trial.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38955-4

By:

Son, Wonyung;
Jeong, Woo Jin;
Park, Jung Min;
Kim, Jung-Yeul;
Ji, Yong-Sok;
Sagong, Min

Publication type:

Article

Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34128-5

By:

Chou, Yun-I.;
Chang, Hao-Yun;
Lin, Meng-Yin;
Tseng, Ching-Han;
Wang, Tsung-Jen;
Lin, I-Chan

Publication type:

Article

Efficient Expression of Functionally Active Aflibercept with Designed N-glycans.

Published in:

Antibodies (2073-4468), 2024, v. 13, n. 2, p. 29, doi. 10.3390/antib13020029

By:

Keshvari, Tahereh;
Melnik, Stanislav;
Sun, Lin;
Niazi, Ali;
Aram, Farzaneh;
Moghadam, Ali;
Kogelmann, Benjamin;
Wozniak-Knopp, Gordana;
Kallolimath, Somanath;
Ramezani, Amin;
Steinkellner, Herta

Publication type:

Article

Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease.

Published in:

Case Reports in Ophthalmological Medicine, 2021, p. 1, doi. 10.1155/2021/8887362

By:

Hsia, Ning-Yi;
Lin, Chun-Ju;
Lai, Chun-Ting;
Bair, Henry;
Chang, Cheng-Hsien;
Lin, Jane-Ming;
Tsai, Yi-Yu

Publication type:

Article

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection.

Published in:

Case Reports in Ophthalmological Medicine, 2020, p. 1, doi. 10.1155/2020/8861435

By:

Suren, Elcin;
Cetinkaya, Ersan;
Kalayci, Mustafa;
Özkan, Sariye Elif Özyazıcı;
Kucuk, Mehmet Fatih;
Erol, Muhammet Kazim

Publication type:

Article

Optic Coherence Tomography Angiography Findings of Bilateral Choroidal Neovascularization Associated with Optic Disc Drusen Treated with Intravitreal Aflibercept Injection.

Published in:

Case Reports in Ophthalmological Medicine, 2020, p. 1, doi. 10.1155/2020/8398054

By:

Akıdan, Melih;
Bulut, Mehmet;
Yaprak, Lütfiye;
Erol, Muhammet Kazım;
Suren, Elcin

Publication type:

Article

Retracted: Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema.

Published in:

2024

By:

International, Emergency Medicine

Publication type:

Correction Notice

Intravitreal Brolucizumab and Aflibercept for Polypoidal Choroidal Vasculopathy.

Published in:

Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 9, p. 653, doi. 10.1089/jop.2023.0030

By:

Cho, Han Joo;
Kang, Kyoung Hae;
Yoon, Wontae;
Lee, Jihyun;
Kim, Chul Gu;
Kim, Jong Woo

Publication type:

Article

Correction to: Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes, by Obata et al. J. Ocul. Pharmacol. Ther 2023;39(3):225–228. DOI: 10.1089/jop.2022.0160.

Published in:: 2023
Publication type:: Correction Notice

Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes.

Published in:

Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 3, p. 225, doi. 10.1089/jop.2022.0160

By:

Obata, Shumpei;
Kakinoki, Masashi;
Sawada, Osamu;
Kawamoto, Ikuo;
Murase, Mitsuru;
Ohji, Masahito

Publication type:

Article

Ocular Pharmacokinetic Properties of Intravitreally Injected Aflibercept in Rabbits After Using Brinzolamide/Timolol Eye Drops.

Published in:

Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 3, p. 229, doi. 10.1089/jop.2022.0146

By:

Zhou, Tianyang;
Li, Xiang;
Yang, Jingjing;
Xia, Huiyun;
Liu, Qian;
He, Jijun;
Zhang, Junjie

Publication type:

Article

Five-Year Reactivation After Ranibizumab or Aflibercept Treatment for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.

Published in:

2021

By:

Kim, Jae Hui;
Kim, Jong Woo;
Kim, Chul Gu

Publication type:

journal article